These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 29483895)
1. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome. Chatoo M; Li Y; Ma Z; Coote J; Du J; Chen X Front Endocrinol (Lausanne); 2018; 9():21. PubMed ID: 29483895 [TBL] [Abstract][Full Text] [Related]
2. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction. Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728 [TBL] [Abstract][Full Text] [Related]
3. Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. o'malley D; Julio-Pieper M; Gibney SM; Gosselin RD; Dinan TG; Cryan JF Neurogastroenterol Motil; 2010 Mar; 22(3):301-11. PubMed ID: 19807869 [TBL] [Abstract][Full Text] [Related]
4. Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management. Elbadawi M; Ammar RM; Rabini S; Klauck SM; Efferth T Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145342 [TBL] [Abstract][Full Text] [Related]
5. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? O'Malley D; Quigley EM; Dinan TG; Cryan JF Brain Behav Immun; 2011 Oct; 25(7):1333-41. PubMed ID: 21536124 [TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. Nozu T; Okumura T J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711 [TBL] [Abstract][Full Text] [Related]
7. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. Fukudo S J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026 [TBL] [Abstract][Full Text] [Related]
8. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Mönnikes H; Tebbe JJ; Hildebrandt M; Arck P; Osmanoglou E; Rose M; Klapp B; Wiedenmann B; Heymann-Mönnikes I Dig Dis; 2001; 19(3):201-11. PubMed ID: 11752838 [TBL] [Abstract][Full Text] [Related]
9. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. O'Malley D; Dinan TG; Cryan JF Peptides; 2010 Apr; 31(4):662-70. PubMed ID: 20096320 [TBL] [Abstract][Full Text] [Related]
14. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome. Taché Y; Martinez V; Million M; Maillot C Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Peripheral CRF Peptide and Water Avoidance Stress on Colonic and Gastric Transit in Guinea Pigs. Hussain Z; Kim HW; Huh CW; Lee YJ; Park H Yonsei Med J; 2017 Jul; 58(4):872-877. PubMed ID: 28541004 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor-Toll-like Receptor 4-Proinflammatory Cytokine Signaling. Nozu T; Okumura T J Neurogastroenterol Motil; 2022 Apr; 28(2):173-184. PubMed ID: 35189599 [TBL] [Abstract][Full Text] [Related]
17. New insights into the pathogenesis and treatment of irritable bowel syndrome. Oświęcimska J; Szymlak A; Roczniak W; Girczys-Połedniok K; Kwiecień J Adv Med Sci; 2017 Mar; 62(1):17-30. PubMed ID: 28135659 [TBL] [Abstract][Full Text] [Related]
18. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M; Hongo M; Fukudo S J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723 [TBL] [Abstract][Full Text] [Related]
19. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183 [TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor induces inflammatory cytokines via the NLRP6-inflammatory cytokine axis in a murine model of irritable bowel syndrome. Yu LM; Zhao KJ; Wang SS; Wang X; Lu B J Dig Dis; 2019 Mar; 20(3):143-151. PubMed ID: 30663229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]